Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions

JCI insight - Tập 2 Số 21 - 2017
Ruth Payne1, Sarah E. Silk1, Sean C. Elias1, Kazutoyo Miura2, Ababacar Diouf2, Francis Galaway3, Hans de Graaf4, Nathan J. Brendish4, Ian Poulton1, Oliver J. Griffiths1, Nick J. Edwards1, Jing Jin1, Geneviève M. Labbé1, Daniel G. W. Alanine1, Loredana Siani5, Stefania Di Marco5, Rachel Roberts1, Nicky Green6, Eleanor Berrie6, Andrew S. Ishizuka1, Carolyn M. Nielsen1, Martino Bardelli1, Frederica Dedo Partey7,8,1, Michael F. Ofori8, Lea Barfod1, Juliana Wambua9, Linda Murungi9,1, Faith Osier9, Sumi Biswas1, James McCarthy10, Angela M. Minassian1, Rebecca Ashfield1, Beate Kampmann11, Fay L. Nugent1, Alexander D. Douglas1, Johan Vekemans12, Gavin J. Wright3, Saul N. Faust4, Adrian V. S. Hill1, Carole A. Long2, Alison M. Lawrie1, Simon J. Draper1
1The Jenner Institute, University of Oxford, Oxford, United Kingdom
2Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA
3Cell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Cambridge, United Kingdom
4NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust and Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
5ReiThera SRL (formerly Okairos SRL), Viale Città d'Europa, Rome, Italy.
6Clinical Biomanufacturing Facility, University of Oxford, Oxford, United Kingdom.
7Centre for Medical Parasitology, Department of Immunology and Microbiology (ISIM), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
8Department of Immunology, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana
9KEMRI Centre for Geographic Medicine Research, Kilifi, Kenya
10QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
11European Vaccine Initiative, UniversitätsKlinikum Heidelberg, Heidelberg, Germany
12GSK Vaccines, Wavre, Belgium

Tóm tắt

Từ khóa


Tài liệu tham khảo

WHO. World Malaria Report 2015. Geneva, Switzerland: World Health Organization; 2015. http://www.who.int/malaria/publications/world-malaria-report-2015/report/en/ Accessed October 10, 2017

Moorthy, 2013, Malaria vaccine technology roadmap, Lancet, 382, 1700, 10.1016/S0140-6736(13)62238-2

Halbroth, 2015, Recent developments in malaria vaccinology, Adv Parasitol, 88, 1, 10.1016/bs.apar.2015.03.001

10.1016/S0140-6736(15)60721-8

10.1016/S1473-3099(17)30104-4

10.1038/ni.f.205

Takala, 2009, Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development, Sci Transl Med, 1, 10.1126/scitranslmed.3000257

10.1371/journal.ppat.1003943

10.1128/CVI.00042-09

10.1111/j.1365-3024.1987.tb00483.x

10.1016/j.vaccine.2015.09.093

Douglas, 2011, The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody, Nat Commun, 2, 10.1038/ncomms1615

10.1073/pnas.1415466112

10.1371/journal.ppat.1002199

10.1016/j.pt.2015.02.001

10.1016/j.ijpara.2008.10.006

10.1371/journal.pone.0003300

10.1371/journal.ppat.1002991

10.1016/j.vaccine.2012.10.106

10.1128/IAI.00970-13

10.1016/j.chom.2008.06.001

Crosnier, 2011, Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum, Nature, 480, 534, 10.1038/nature10606

10.1093/infdis/jit553

Villasis, 2012, Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru, Malar J, 11, 10.1186/1475-2875-11-361

10.4049/jimmunol.1300778

10.1126/scitranslmed.3008705

10.1016/j.molbiopara.2012.12.005

10.1073/pnas.1320771110

Galaway, 2017, P113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5, Nat Commun, 8, 10.1038/ncomms14333

10.1016/j.chom.2016.06.004

10.1111/cmi.12747

10.1038/nm.1850

10.1586/erv.13.11

10.1016/j.chom.2014.11.017

10.4049/jimmunol.1001760

10.1093/infdis/jir850

10.1371/journal.pone.0115161

10.1038/mt.2011.176

10.1371/journal.pone.0031208

10.1371/journal.pone.0024586

10.1038/mt.2016.83

10.1038/mt.2014.109

Payne, 2017, Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies, JCI Insight, 2, 10.1172/jci.insight.93683

10.1056/NEJMoa1411627

Barnes, 2012, Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man, Sci Transl Med, 4, 10.1126/scitranslmed.3003155

10.1126/scitranslmed.aac5745

10.1038/mt.2013.248

10.1038/mt.2011.176

10.1038/nature13715

Chen, 2014, Crystal structure of PfRh5, an essential P. falciparum ligand for invasion of human erythrocytes, Elife, 3, 10.7554/eLife.04187

10.1111/imm.12226

10.1038/mt.2014.157

10.1093/infdis/jiw039

10.1038/mt.2012.223

10.1128/IAI.00414-16

10.4049/jimmunol.1302045

10.1016/j.vaccine.2013.03.020

10.1126/scitranslmed.3009185

10.1073/pnas.1220360110

10.1016/j.chom.2008.12.004

10.4049/jimmunol.1502137

10.4049/jimmunol.1502472

10.1371/journal.pone.0107903

Weaver, 2016, The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria, Sci Rep, 6, 10.1038/srep33094

10.1016/j.immuni.2015.02.012

10.1038/nature11174

Ord, 2014, A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein, Malar J, 13, 10.1186/1475-2875-13-326

Chen, 2017, Structural basis for inhibition of erythrocyte invasion by antibodies to Plasmodium falciparum protein CyRPA, Elife, 6, 10.7554/eLife.21347

Hjerrild, 2016, Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system, Sci Rep, 6, 10.1038/srep30357

10.1128/IAI.73.6.3677-3685.2005

10.1101/gr.7187808